- Home
- Publications
- Publication Search
- Publication Details
Title
PROTAC targeted protein degraders: the past is prologue
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-19
DOI
10.1038/s41573-021-00371-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Rise of Molecular Glues
- (2021) Stuart L. Schreiber CELL
- Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1
- (2021) Adam D. Cotton et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Functional Genomics Identify Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of Oncoproteins
- (2021) Ryosuke Shirasaki et al. Cell Reports
- Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties
- (2021) Peter S. Dragovich et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy
- (2021) Peter S. Dragovich et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ubiquitin ligation to F-box protein targets by SCF–RBR E3–E3 super-assembly
- (2021) Daniel Horn-Ghetko et al. NATURE
- Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide
- (2021) Max Jan et al. Nature Reviews Clinical Oncology
- Tau: Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies
- (2021) Che-Wei Chang et al. SCIENCE
- Targeting oncoproteins with a positive selection assay for protein degraders
- (2021) Vidyasagar Koduri et al. Science Advances
- Transforming targeted cancer therapy with PROTACs: A forward-looking perspective
- (2021) William Farnaby et al. CURRENT OPINION IN PHARMACOLOGY
- Targeted protein degraders crowd into the clinic
- (2021) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Nanotechnology advances in pathogen- and host-targeted antiviral delivery: multipronged therapeutic intervention for pandemic control
- (2021) Kai-Chieh Yang et al. Drug Delivery and Translational Research
- Persistent repression of tau in the brain using engineered zinc finger protein transcription factors
- (2021) Susanne Wegmann et al. Science Advances
- In vitro and in vivo degradation of programmed cell death ligand 1 (PD-L1) by a proteolysis targeting chimera (PROTAC)
- (2021) Yubo Wang et al. BIOORGANIC CHEMISTRY
- Strategies toward Discovery of Potent and Orally Bioavailable Proteolysis Targeting Chimera Degraders of Androgen Receptor for the Treatment of Prostate Cancer
- (2021) Xin Han et al. JOURNAL OF MEDICINAL CHEMISTRY
- TF-PROTACs Enable Targeted Degradation of Transcription Factors
- (2021) Jing Liu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Harnessing the E3 Ligase KEAP1 for Targeted Protein Degradation
- (2021) Jieli Wei et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Highly accurate protein structure prediction for the human proteome
- (2021) Kathryn Tunyasuvunakool et al. NATURE
- The PROTACtable genome
- (2021) Melanie Schneider et al. NATURE REVIEWS DRUG DISCOVERY
- Accurate prediction of protein structures and interactions using a three-track neural network
- (2021) Minkyung Baek et al. SCIENCE
- Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer
- (2021) Sebastian M. Dieter et al. Cell Reports
- Unifying Catalysis Framework to Dissect Proteasomal Degradation Paradigms
- (2021) Frances P. Rodriguez-Rivera et al. ACS Central Science
- PROTAC cell permeability and oral bioavailability: a journey into uncharted territory
- (2021) Vasanthanathan Poongavanam et al. Future Medicinal Chemistry
- Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
- (2020) George M. Burslem et al. CELL
- Discovery of CRBN E3 Ligase Modulator CC-92480 for the Treatment of Relapsed and Refractory Multiple Myeloma
- (2020) Joshua D. Hansen et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3′ End Processing Complex
- (2020) Seung Wook Yang et al. MOLECULAR CELL
- Harnessing the Power of Proteolysis for Targeted Protein Inactivation
- (2020) Rati Verma et al. MOLECULAR CELL
- NEDD8 nucleates a multivalent cullin–RING–UBE2D ubiquitin ligation assembly
- (2020) Kheewoong Baek et al. NATURE
- bioPROTACs as versatile modulators of intracellular therapeutic targets including proliferating cell nuclear antigen (PCNA)
- (2020) Shuhui Lim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives
- (2020) Yuan Fang et al. Acta Pharmaceutica Sinica B
- Prey for the Proteasome: Targeted Protein Degradation – A Medicinal Chemist´s Perspective
- (2020) Laura M. Luh et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics
- (2020) Arun K. Ghosh et al. ChemMedChem
- Discovery of PROTAC BCL-XL degraders as potent anticancer agents with low on-target platelet toxicity
- (2020) Xuan Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Investigational IRAK-4 inhibitors for the treatment of rheumatoid arthritis
- (2020) Michael D. Wiese et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- First-in-human phase I study of ARV-110, an androgen receptor (AR) PROTAC degrader in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) following enzalutamide (ENZ) and/or abiraterone (ABI).
- (2020) Daniel Peter Petrylak et al. JOURNAL OF CLINICAL ONCOLOGY
- Multispecific drugs herald a new era of biopharmaceutical innovation
- (2020) Raymond J. Deshaies NATURE
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics
- (2020) Sajid Khan et al. ONCOGENE
- Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
- (2020) Wanchao Yin et al. SCIENCE
- Targeting the E3 ubiquitin ligases DCAF15 and cereblon for cancer therapy
- (2020) Khai M. Nguyen et al. SEMINARS IN CANCER BIOLOGY
- Emerging New Concepts of Degrader Technologies
- (2020) Yu Ding et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Viral gene delivery vectors: the next generation medicines for immune-related diseases
- (2020) Peter De Haan et al. Human Vaccines & Immunotherapeutics
- A Nimbolide-Based Kinase Degrader Preferentially Degrades Oncogenic BCR-ABL
- (2020) Bingqi Tong et al. ACS Chemical Biology
- Multiple Cereblon genetic changes associate with acquired resistance to Lenalidomide or Pomalidomide in Multiple Myeloma
- (2020) Sarah Gooding et al. BLOOD
- Targeted protein degradation: current and future challenges
- (2020) Alexander Hanzl et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
- (2020) Yonghan He et al. Journal of Hematology & Oncology
- DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas
- (2020) Yonghan He et al. Journal of Hematology & Oncology
- Lysosome-targeting chimaeras for degradation of extracellular proteins
- (2020) Steven M. Banik et al. NATURE
- The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K
- (2020) Mikołaj Słabicki et al. NATURE
- Rational discovery of molecular glue degraders via scalable chemical profiling
- (2020) Cristina Mayor-Ruiz et al. Nature Chemical Biology
- RAS-targeted therapies: is the undruggable drugged?
- (2020) Amanda R. Moore et al. NATURE REVIEWS DRUG DISCOVERY
- Targeted protein degradation as a powerful research tool in basic biology and drug target discovery
- (2020) Tao Wu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Opportunities for Small Molecules in Cancer Immunotherapy
- (2020) Sabina Y. van der Zanden et al. TRENDS IN IMMUNOLOGY
- Targeted Degradation of Oncogenic KRASG12C by VHL-Recruiting PROTACs
- (2020) Michael J. Bond et al. ACS Central Science
- Strategies to Investigate Ubiquitination in Huntington's Disease
- (2020) Karen A. Sap et al. Frontiers in Chemistry
- Hematopoietic Progenitor Kinase1 (HPK1) Mediates T Cell Dysfunction and Is a Druggable Target for T Cell-Based Immunotherapies
- (2020) Jingwen Si et al. CANCER CELL
- Could PROTACs Protect Us From COVID-19?
- (2020) Wilnelly Martinez-Ortiz et al. DRUG DISCOVERY TODAY
- Kinase inhibition in autoimmunity and inflammation
- (2020) Ali A. Zarrin et al. NATURE REVIEWS DRUG DISCOVERY
- PROTAC-DB: an online database of PROTACs
- (2020) Gaoqi Weng et al. NUCLEIC ACIDS RESEARCH
- Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules
- (2020) Behnam Nabet et al. Nature Communications
- RNA‐PROTACs: Degraders of RNA‐Binding Proteins
- (2020) Alice Ghidini et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Tailored Bioorthogonal and Bioconjugate Chemistry: A Source of Inspiration for Developing Kinetic Target-Guided Synthesis Strategies
- (2020) Alexis Lossouarn et al. BIOCONJUGATE CHEMISTRY
- CC-90009, a novel cereblon E3 ligase modulator targets acute myeloid leukemia blasts and leukemia stem cells
- (2020) Christine Surka et al. BLOOD
- Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development
- (2020) Katherine A. Donovan et al. CELL
- The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis
- (2020) Shalini Menon et al. MOLECULAR BIOLOGY OF THE CELL
- Snapshots and ensembles of BTK and cIAP1 protein degrader ternary complexes
- (2020) James Schiemer et al. Nature Chemical Biology
- Solution Conformations Shed Light on PROTAC Cell Permeability
- (2020) Yoseph Atilaw et al. ACS Medicinal Chemistry Letters
- Design, Synthesis, and Biological Evaluation of IRAK4-Targeting PROTACs
- (2020) Yun Chen et al. ACS Medicinal Chemistry Letters
- Exquisitely Specific anti-KRAS Biodegraders Inform on the Cellular Prevalence of Nucleotide-Loaded States
- (2020) Shuhui Lim et al. ACS Central Science
- Small-Molecule Approaches to Targeted Protein Degradation
- (2020) Tyler B. Faust et al. Annual Review of Cancer Biology-Series
- Building ubiquitination machineries: E3 ligase multi-subunit assembly and substrate targeting by PROTACs and molecular glues
- (2020) Sarath Ramachandran et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- NEDD8 and ubiquitin ligation by cullin-RING E3 ligases
- (2020) Kheewoong Baek et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Mechanisms of substrate recognition by the 26S proteasome
- (2020) Caroline Davis et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction
- (2019) Kyle R. Simonetta et al. Nature Communications
- Matrix Mediated Viral Gene Delivery: A Review
- (2019) Douglas Steinhauff et al. BIOCONJUGATE CHEMISTRY
- PROTAC-Mediated Degradation of Bruton’s Tyrosine Kinase Is Inhibited by Covalent Binding
- (2019) Christopher P. Tinworth et al. ACS Chemical Biology
- Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications
- (2019) Carl C. Ward et al. ACS Chemical Biology
- New Electrophiles and Strategies for Mechanism-Based and Targeted Covalent Inhibitor Design
- (2019) Sneha Ray et al. BIOCHEMISTRY
- Targeting Nuclear Receptors with PROTAC degraders
- (2019) John J. Flanagan et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Acquired Resistance to BET-PROTACs(Proteolysis Targeting Chimeras) Caused by Genomic Alterations in Core Components of E3 ligase Complexes
- (2019) Lu Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models
- (2019) M Catarina Silva et al. eLife
- Advances in targeted degradation of endogenous proteins
- (2019) Sascha Röth et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Harnessing the anti-cancer natural product nimbolide for targeted protein degradation
- (2019) Jessica N. Spradlin et al. Nature Chemical Biology
- BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design
- (2019) William Farnaby et al. Nature Chemical Biology
- Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16
- (2019) Xiaoyu Zhang et al. Nature Chemical Biology
- Molecular mechanisms of cereblon-based drugs
- (2019) Tomoko Asatsuma-Okumura et al. PHARMACOLOGY & THERAPEUTICS
- Targeting IRAK4 for Degradation with PROTACs
- (2019) Joao Nunes et al. ACS Medicinal Chemistry Letters
- Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations
- (2019) Mélissanne de Wispelaere et al. Nature Communications
- IKZF1/3 and CRL4-CRBN E3 ubiquitin ligase mutations and IMiD resistance in multiple myeloma
- (2019) Santiago Barrio et al. HAEMATOLOGICA
- Development of targeted protein degradation therapeutics
- (2019) Philip P. Chamberlain et al. Nature Chemical Biology
- Degradation of proteins by PROTACs and other strategies
- (2019) Yang Wang et al. Acta Pharmaceutica Sinica B
- Cancer Testis Antigens in Sarcoma: Expression, Function and Immunotherapeutic Application
- (2019) Ran Wei et al. CANCER LETTERS
- Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity
- (2019) Thomas H. Pillow et al. ChemMedChem
- The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
- (2019) Jude Canon et al. NATURE
- Allele-selective lowering of mutant HTT protein by HTT–LC3 linker compounds
- (2019) Zhaoyang Li et al. NATURE
- Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15
- (2019) Tyler B. Faust et al. Nature Chemical Biology
- Targeted protein degradation: expanding the toolbox
- (2019) Matthieu Schapira et al. NATURE REVIEWS DRUG DISCOVERY
- Structural Basis and Kinetic Pathway of RBM39 Recruitment to DCAF15 by a Sulfonamide Molecular Glue E7820
- (2019) Xinlin Du et al. STRUCTURE
- Evolution of Cereblon-Mediated Protein Degradation as a Therapeutic Modality
- (2019) Philip P. Chamberlain et al. ACS Medicinal Chemistry Letters
- Structural basis of Cullin 2 RING E3 ligase regulation by the COP9 signalosome
- (2019) Sarah V. Faull et al. Nature Communications
- The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
- (2019) Jill Hallin et al. Cancer Discovery
- Aryl Sulfonamides Degrade RBM39 and RBM23 by Recruitment to CRL4-DCAF15
- (2019) Tabitha C. Ting et al. Cell Reports
- AUTACs: Cargo-Specific Degraders Using Selective Autophagy
- (2019) Daiki Takahashi et al. MOLECULAR CELL
- Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex
- (2019) Dirksen E. Bussiere et al. Nature Chemical Biology
- A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
- (2019) Sajid Khan et al. NATURE MEDICINE
- Targeted Protein Degradation by Chimeric Small Molecules, PROTACs and SNIPERs
- (2019) Mikihiko Naito et al. Frontiers in Chemistry
- Targeting the C481S Ibrutinib-Resistance Mutation in Bruton’s Tyrosine Kinase Using PROTAC-Mediated Degradation
- (2018) Alexandru D. Buhimschi et al. BIOCHEMISTRY
- Practical application of ligand efficiency metrics in lead optimisation
- (2018) James S. Scott et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor
- (2018) Matthew R. Janes et al. CELL
- PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies
- (2018) Yonghui Sun et al. CELL RESEARCH
- Discovery of a Keap1-dependent peptide PROTAC to knockdown Tau by ubiquitination-proteasome degradation pathway
- (2018) Mengchen Lu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations
- (2018) Robert J. Young et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lipophilic Efficiency as an Important Metric in Drug Design
- (2018) Ted W. Johnson et al. JOURNAL OF MEDICINAL CHEMISTRY
- The dTAG system for immediate and target-specific protein degradation
- (2018) Behnam Nabet et al. Nature Chemical Biology
- Plasticity in binding confers selectivity in ligand-induced protein degradation
- (2018) Radosław P. Nowak et al. Nature Chemical Biology
- Delineating the role of cooperativity in the design of potent PROTACs for BTK
- (2018) Adelajda Zorba et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Principles of Ubiquitin-Dependent Signaling
- (2018) Eugene Oh et al. Annual Review of Cell and Developmental Biology
- Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807
- (2018) David T. Chien et al. JOURNAL OF ALZHEIMERS DISEASE
- Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs
- (2018) Michael D. Shultz JOURNAL OF MEDICINAL CHEMISTRY
- Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome
- (2018) Katherine A Donovan et al. eLife
- UbiHub: a data hub for the explorers of ubiquitination pathways
- (2018) Lihua Liu et al. BIOINFORMATICS
- Bruton's Tyrosine Kinase degradation as a therapeutic strategy for cancer
- (2018) Dennis Dobrovolsky et al. BLOOD
- Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function
- (2018) Eric Shifrut et al. CELL
- The Next Generation of Immunotherapy for Cancer: Small Molecules Could Make Big Waves
- (2018) William G. Kerr et al. JOURNAL OF IMMUNOLOGY
- Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN
- (2018) Quinlan L. Sievers et al. SCIENCE
- Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders
- (2017) Scott J. Hughes et al. Essays in Biochemistry
- A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos
- (2017) Mary E. Matyskiela et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Comprehensive Guide to the MAGE Family of Ubiquitin Ligases
- (2017) Anna K. Lee et al. JOURNAL OF MOLECULAR BIOLOGY
- Selective degradation of splicing factor CAPERα by anticancer sulfonamides
- (2017) Taisuke Uehara et al. Nature Chemical Biology
- Structural basis of PROTAC cooperative recognition for selective protein degradation
- (2017) Morgan S Gadd et al. Nature Chemical Biology
- Targeted protein degradation by PROTACs
- (2017) Taavi K. Neklesa et al. PHARMACOLOGY & THERAPEUTICS
- Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15
- (2017) Ting Han et al. SCIENCE
- Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy
- (2017) Sarah L. DeVos et al. Science Translational Medicine
- Structural Studies of HHARI/UbcH7∼Ub Reveal Unique E2∼Ub Conformational Restriction by RBR RING1
- (2017) Katja K. Dove et al. STRUCTURE
- Two Distinct Types of E3 Ligases Work in Unison to Regulate Substrate Ubiquitylation
- (2016) Daniel C. Scott et al. CELL
- System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes
- (2016) Wei Zhang et al. MOLECULAR CELL
- A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase
- (2016) Mary E. Matyskiela et al. NATURE
- Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53
- (2016) Denise Martinez-Zapien et al. NATURE
- Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
- (2016) Ying-Nan P. Chen et al. NATURE
- Structural basis of lenalidomide-induced CK1α degradation by the CRL4CRBN ubiquitin ligase
- (2016) Georg Petzold et al. NATURE
- The increasing complexity of the ubiquitin code
- (2016) Richard Yau et al. NATURE CELL BIOLOGY
- The DDB1–DCAF1–Vpr–UNG2 crystal structure reveals how HIV-1 Vpr steers human UNG2 toward destruction
- (2016) Ying Wu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Tripartite degrons confer diversity and specificity on regulated protein degradation in the ubiquitin-proteasome system
- (2016) Mainak Guharoy et al. Nature Communications
- The DDB1–DCAF1–Vpr–UNG2 crystal structure reveals how HIV-1 Vpr steers human UNG2 toward destruction
- (2016) Ying Wu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A recombinant chimeric protein specifically induces mutant KRAS degradation and potently inhibits pancreatic tumor growth
- (2016) Ting Pan et al. Oncotarget
- An affinity-directed protein missile system for targeted proteolysis
- (2016) Luke J. Fulcher et al. Open Biology
- HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins
- (2015) Dennis L. Buckley et al. ACS Chemical Biology
- Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
- (2015) Michael Zengerle et al. ACS Chemical Biology
- Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL
- (2015) Ashton C. Lai et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Degradation of AMPK by a Cancer-Specific Ubiquitin Ligase
- (2015) Carlos T. Pineda et al. CELL
- The MAGE protein family and cancer
- (2015) Jenny L Weon et al. CURRENT OPINION IN CELL BIOLOGY
- Comparison of plant hormone signalling systems
- (2015) A. Larrieu et al. Essays in Biochemistry
- Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast Cancer
- (2015) Donald P. McDonnell et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
- (2015) Jan Krönke et al. NATURE
- Catalytic in vivo protein knockdown by small-molecule PROTACs
- (2015) Daniel P Bondeson et al. Nature Chemical Biology
- Tau in physiology and pathology
- (2015) Yipeng Wang et al. NATURE REVIEWS NEUROSCIENCE
- The Structural Differences between a Glycoprotein Specific F-Box Protein Fbs1 and Its Homologous Protein FBG3
- (2015) Taichi Kumanomidou et al. PLoS One
- Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
- (2014) Bradley Croy Doak et al. CHEMISTRY & BIOLOGY
- KLHL40 deficiency destabilizes thin filament proteins and promotes nemaline myopathy
- (2014) Ankit Garg et al. JOURNAL OF CLINICAL INVESTIGATION
- E3 ubiquitin ligases and human papillomavirus-induced carcinogenesis
- (2014) Zhifeng Lou et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Structure of the DDB1–CRBN E3 ubiquitin ligase in complex with thalidomide
- (2014) Eric S. Fischer et al. NATURE
- Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif
- (2014) Yingying Guo et al. NATURE
- Identification of KLHL41 Mutations Implicates BTB-Kelch-Mediated Ubiquitination as an Alternate Pathway to Myofibrillar Disruption in Nemaline Myopathy
- (2013) Vandana A. Gupta et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN
- (2013) Anita K. Gandhi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Targeted Degradation of KRAS by an Engineered Ubiquitin Ligase Suppresses Pancreatic Cancer Cell Growth In Vitro and In Vivo
- (2013) Y. Ma et al. MOLECULAR CANCER THERAPEUTICS
- K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
- (2013) Jonathan M. Ostrem et al. NATURE
- Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
- (2013) J. Kronke et al. SCIENCE
- The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
- (2013) G. Lu et al. SCIENCE
- Mechanism of ubiquitin ligation and lysine prioritization by a HECT E3
- (2013) Hari B Kamadurai et al. eLife
- Small-Molecule Inhibitors of the Interaction between the E3 Ligase VHL and HIF1α
- (2012) Dennis L. Buckley et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The Ubiquitin Code
- (2012) David Komander et al. Annual Review of Biochemistry
- Structural Insights into the Conformation and Oligomerization of E2∼Ubiquitin Conjugates
- (2012) Richard C. Page et al. BIOCHEMISTRY
- Targeting the von Hippel–Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α Interaction
- (2012) Dennis L. Buckley et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Structural regulation of cullin-RING ubiquitin ligase complexes
- (2011) David M Duda et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Fluorescent fusion protein knockout mediated by anti-GFP nanobody
- (2011) Emmanuel Caussinus et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structural assembly of cullin-RING ubiquitin ligase complexes
- (2010) Erik S Zimmerman et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Roles of Vpr and Vpx in modulating the virus-host cell relationship
- (2010) Vicente Planelles et al. MOLECULAR ASPECTS OF MEDICINE
- Impact of linker length on the activity of PROTACs
- (2010) Kedra Cyrus et al. Molecular BioSystems
- Identification of a Primary Target of Thalidomide Teratogenicity
- (2010) T. Ito et al. SCIENCE
- Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
- (2009) Ellen M. Sletten et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Diversity in Tissue Expression, Substrate Binding, and SCF Complex Formation for a Lectin Family of Ubiquitin Ligases
- (2008) Kevin A. Glenn et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A novel brain-enriched E3 ubiquitin ligase RNF182 is up regulated in the brains of Alzheimer's patients and targets ATP6V0C for degradation
- (2008) Qing Liu et al. Molecular Neurodegeneration
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started